17117-13-4

Basic information

• Product Name: 2-Bromo-4-ethoxypyridine
• Synonyms: 2-Bromo-4-ethoxypyridine
• CAS NO: 17117-13-4
• Molecular Formula: C₇H₈BrNO
• Molecular Weight: 202.04852
• Mol File: 17117-13-4.mol
• Article Data: 1

Chemical Properties

• Melting Point: 38 °C
• Boiling Point: 247.3°Cat760mmHg
• Flash Point: 103.4°C
• Appearance: /
• Density: 1.449g/cm³
• Vapor Pressure: 0.0407mmHg at 25°C
• Refractive Index: 1.534
• Storage Temp.: Inert atmosphere,Room Temperature
• PKA: 2.10±0.10(Predicted)
• CAS DataBase Reference: 2-Bromo-4-ethoxypyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Bromo-4-ethoxypyridine(17117-13-4)
• EPA Substance Registry System: 2-Bromo-4-ethoxypyridine(17117-13-4)

Safety Data

• Hazardous Substances Data: 17117-13-4(Hazardous Substances Data)

Usage

General Description

2-Bromo-4-ethoxypyridine is a specialty chemical compound. It is generally recognized by its systematic name, 1-bromo-4-ethoxy-2-pyridine. The corresponding CAS Registry Number is 13386-40-4. It is used in the field of organic synthesis, particularly in the preparation of pharmaceuticals and agrochemicals. The chemical belongs to the class of compounds known as bromopyridines which are organic compounds containing a pyridine ring which bears a bromine atom. Its molecular formula is C7H8BrNO with an average mass of 202.045 g/mol and a monoisotopic mass of 201.958 g/mol. Generally, as an organic halogen compound, it has a bromine atom attached to it, making it reactive and useful in several chemical processes.

InChI:InChI=1/C7H8BrNO/c1-2-10-6-3-4-9-7(8)5-6/h3-5H,2H2,1H3

Upstream product

• 6945-67-1 2-bromo-4-nitropyridine 

Downstream Products

• 289469-67-6 4-ethoxy-2-(3-nitrophenyl)pyridine 
• 1447725-99-6 2-(3,5-bis-(4-fluoro-phenyl)-(1,2,4)triazol-1-yl)-1-(4-(4-ethoxy-pyridin-2-yl)-piperazin-1-yl)-ethanone 

Relevant articles and documents

Pyridine compounds and their pharmaceutical use

A compound of formula (I) wherein each symbol is as defined in the specification, and pharmaceutically acceptable salts thereof. The compound (I) of the present invention and pharmaceutically acceptable salts thereof possess a strong inhibitory activity on the production of nitric oxide (NO), and are useful for prevention and/or treatment of NOS(nitric oxide synthasey)-mediated diseases such as adult respiratory distress syndrome, myocarditis, synovitis, septic shock, insulin-ependent diabetes mellitus, ulcerative colitis, cerebral infarction, rheumatoid arthritis, osteoarthritis, osteoporosis, systemic lupus erythematosus, rejection by organ transplantation, asthma, pain, ulcer, and the like in human being and animals.